Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-03

FDA Approved: VOQUEZNA TRIPLE PAK — Original Application (Phathom Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Voquezna Triple Pak, a combination therapy of vonoprazan fumarate, amoxicillin, and clarithromycin, for the treatment of Helicobacter pylori in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOQUEZNA TRIPLE PAK (VONOPRAZAN FUMARATE, AMOXICILLIN AND CLARITHROMYCIN)

Snippet

ORIG AP for VOQUEZNA TRIPLE PAK (VONOPRAZAN FUMARATE, AMOXICILLIN AND CLARITHROMYCIN)